Startseite › Eierstockkrebs › Colorado › Aurora
Klinische Studien zu Eierstockkrebs in Aurora, CO
25 Studien zu Eierstockkrebs suchen Teilnehmer an Standorten in und um Aurora (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Teilnehmer gesuchtPhase 2/3
- UCHealth University of Colorado Hospital, Aurora
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Teilnehmer gesuchtPhase 2
- UCHealth University of Colorado Hospital, Aurora
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Research Site, Aurora
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Teilnehmer gesuchtPhase 2
- University of Colorado Hospital- Aurora /ID# 278232, Aurora
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
Teilnehmer gesuchtPhase 1/2
- University of Colorado Denver, Aurora
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Teilnehmer gesuchtPhase 3
- Anschutz Cancer Pavilion, Aurora
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Colorado Cancer Center, Aurora
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Colorado Cancer Center, Aurora
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Teilnehmer gesuchtPhase 3
- University of Colorado Cancer Center, Aurora
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Teilnehmer gesuchtBeobachtungsstudie
- University of Colorado, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Teilnehmer gesuchtPhase 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Teilnehmer gesuchtPhase 1/2
- Children's Hospital Colorado, Aurora
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Teilnehmer gesucht
- UCHealth University of Colorado Hospital, Aurora
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Teilnehmer gesuchtPhase 3
- UCHealth University of Colorado Hospital, Aurora
Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer
Teilnehmer gesuchtPhase 1
- CU Medicine Clinics, Aurora
- Universtiy of Colorado Hospital, Aurora
An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib
Teilnehmer gesuchtPhase 2
- University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Colorado Cancer Center, Aurora
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
Teilnehmer gesucht
- University of Colorado Anschutz Medical Campus, Aurora
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Teilnehmer gesuchtPhase 1/2
- University of Colorado, Anschutz Medical Campus, Aurora
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
Teilnehmer gesuchtPhase 3
- University of Colorado Hospital - Anshutz Cancer Pavilion, Aurora
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
Teilnehmer gesucht
- University of Colorado Cancer Center-Anschutz, Aurora
A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer
Teilnehmer gesuchtPhase 1
- Site 0264, Aurora
Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis
Teilnehmer gesuchtPhase 1
- University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Aurora
Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
Teilnehmer gesucht
- University of Colorado, Aurora
Eierstockkrebs-Studien in anderen Städten
- Houston, TX89 Studien
- New York City, NY69 Studien
- Boston, MA61 Studien
- Los Angeles, CA50 Studien
- Nashville, TN49 Studien
- Arlington, VA46 Studien
- Philadelphia, PA44 Studien
- Columbus, OH39 Studien
- St. Louis, MO38 Studien
- Chicago, IL36 Studien
- San Antonio, TX31 Studien
- Cleveland, OH30 Studien
Weitere Studien in Aurora
- Krebs (alle Arten)35 Studien
- Kolorektales Karzinom32 Studien
- Nichtkleinzelliges Lungenkarzinom31 Studien
- Brustkrebs28 Studien
- Metastasierender Krebs25 Studien
- Typ-1-Diabetes23 Studien
- Adipositas22 Studien
- Prostatakrebs19 Studien
- Lungenkrebs19 Studien
- Herzinsuffizienz18 Studien
- Melanom18 Studien
- Akute myeloische Leukämie16 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.